In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Summary: A new study reveals that when interacting with AI tools like ChatGPT, everyone—regardless of skill level—overestimates their performance. Researchers found that the usual Dunning-Kruger ...

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States Oden Institute for Computational Engineering and Sciences, The University of Texas at Austin ...

While inflation is down from a year ago, it has recently started to creep back upward again. When you throw in high interest rates and declining wage growth, many Americans are feeling the financial ...

WASHINGTON, Aug 13 (Reuters) - Two major environmental groups announced on Tuesday they have sued the Trump administration for secretly convening a group of climate skeptics, which prepared a report ...

Defense technology company Booz Allen Hamilton Inc. today announced the launch of Vellox Reverser, an artificial intelligence cloud product that protects organizations from malware as cyberattacks ...

phpstan 2.1.18 crashes with an out-of-memory or with --xdebug (and a sufficiently high memory limit) this error: Internal error: Maximum call stack size of 8339456 bytes (zend.max_allowed_stack_size - ...

Abstract: Multiple parallel sparse linear arrays (MPSLAs) can be strategically deployed in two-dimensional (2D) or threedimensional (3D) space, offering a unique advantage by enabling easy conformal ...

Recursion's stock has been consistently rated as "Hold" by this analyst due to skepticism about its AI-driven drug discovery approach and its financial instability. The company's IPO raised over $500 ...